BUMITAMA AGRI LTD
P8Z.SI
Bumitama Agri (BAL SP) - No earnings surprises
Still a value buy
- FY15 core PATMI met 103%/100% of our/consensus estimates.
- We expect 17% EPS recovery in 2016 underpinned by stronger output and higher CPO prices.
- Our 2016-18F forecasts incorporated FRS16 & FRS41 accounting impact effective 1 Jan 2016.
- At 11.5x 2016 PER, BAL is still undervalued despite the recent rebound in stock price.
- Maintain BUY and TP of SGD0.85 based on 13x 2016 PER.
FY15 results within expectations
- FY15 headline PATMI was down 23% YoY to IDR891b.
- Stripping fair valuation loss on biological assets (IDR46b) and FX translation losses (IDR52b), core PATMI came in at IDR964b (-22% YoY), within expectations.
- The lower YoY PATMI was due to lower CPO ASP (-16% YoY) and higher cost of production (in part due to the weaker rupiah) but mitigated by higher FFB nucleus output (+13% YoY) and lower effective tax rate of 18% (-5.9 ppts YoY).
- A final DPS will only be announced closer to AGM date.
Good output growth of 13% in 2015
- Operationally, BAL posted a relatively good FFB nucleus output growth (1.58m MT, +13% YoY) in FY15 despite 3Q15’s drought that hit its estates. And we estimate its FY15’s all-in cost of production at ~MYR1,000/t (excluding FX loss and FV losses on biological assets), still one of the more cost efficient producers in the region.
BUY; medium-term growth outlook intact
- BAL’s FFB (group) growth guidance of 8% (MKE: +14% YoY) for 2016 appears conservative in our view given its young age profile of 8 years.
- For FY16, we are maintaining our 14% FFB nucleus growth forecasts and MYR2,300/t CPO ASP assumption for now.
- BUY BAL for its long-term prospects and 23% 2015-17 EPS CAGR.
- Our TP is unchanged at SGD0.85 based on an undemanding 13x 2016 PER; -1SD below its historical mean.
Ong Chee Ting CA
Maybank Kim Eng
|
http://www.maybank-ke.com.sg/
2016-02-23
Maybank Kim Eng
SGX Stock
Analyst Report
0.85
Same
0.85